Understanding molecular modifications of proteins in the red yeast could help scientists re-engineer the organism’s phenotype.

Continued studies will deepen scientists’ understanding of virus-host interactions at the molecular level and also pave the way for developing better drugs to fight emerging viruses.

Flexible, high-throughput proteomics approach identifies protein modifications related to pancreatic stress and insulin production.

Scientists uncover how cyanobacteria's circadian cycle controls carbon and energy metabolism, increasing carbon dioxide-to-bioproducts yields.

Scientists map how transitions from day to night control gene regulatory networks in cyanobacteria, revealing key orchestrators of metabolic switching.

PNNL scientists use proteomics to unveil how high-density lipoproteins protect against cholesterol accumulation in the artery wall.

Computing and artificial intelligence aid scientists who seek to understand function-driven design and control of biological systems.

A new mini-acoustic transmitter and tagging procedure is able to provide data on small, sensitive fish species like the American shad.

New methodological approach demonstrates how to assess the economic value, including non-traditional value streams, of converting non-powered dams to hydroelectric facilities.

The new PTM-Psi workflow opens the door for uncovering molecular insights within proteomics datasets.

Researchers designed ultra-low radiation cables to reduce background noise for highly sensitive neutrino and dark matter detectors.

Developed with community input, the new Hydropower Vision Roadmap lays out a path to achieve a shared vison for modern hydropower by 2050.

PNNL’s Richard Saldanha will lead a new project to benchmark and validate models of cosmic ray exposure

Scientists developed a process (or pipeline) that combined molecular probes—a specific chemical that binds to microbes carrying out a particular function—with a method that isolated these cells from their complex community.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.